IRVINE, Calif. (AP) — IRVINE, Calif. (AP) — OncoCyte Corp. (OCX) on Thursday reported a loss of $4.6 million in its second quarter.
The Irvine, California-based company said it had a loss of 36 cents per share.
The cancer diagnostic test developer posted revenue of $104,000 in the period.
_____
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on OCX at https://www.zacks.com/ap/OCX
